Cancer Program Annual Report 2017

FEATURE: An Overview of Uterine Cancer

Nathan D. Stice, M.D.

Uterine cancer is the most common gynecologic malignancy in the United States and the 4th leading new cancer diagnosis in females. This year, an estimated 63,230 women will be diagnosed with uterine cancer. There is an 81.1% five -year survival rate and early detection is the key. If the cancer is found in stage one, the five-year survival rate is 94.9%. New uterine cancer rates are increasing an average of 1.3% every year and has been for the past 10 years.

Unlike many other cancers, uterine cancer (specifically endometrial cancer) has warning signs and can lead to early diagnosis and early treatment, which often leads to a complete cure.

What is endometrial cancer?
The most common form of uterine cancer is also called endometrial cancer. The lining of the uterus is known as the endometrium, and is the layer of the uterus that sheds when a female is menstruating. These cells can undergo hyperplasia if not shed regularly. After many years, this hyperplasia can become endometrial cancer.

[Read Full Article]


Click links below to see 2017 statistics on Uterine Cancer.


Click icon to jump to story or scroll to read all

3D Mammography

Improvements continued in 2017 throughout various aspects of the cancer program. The number of 3-D mammograms (tomosynthesis) increased significantly as approximately half of all mammogram patients elected to have this enhanced digital breast examination. A more thorough screening exam can be a psychological and economic benefit to the patient by reducing the number of women called back for additional imaging after screening mammography. As additional time passes, we anticipate more and more women will opt for this new, thorough technology.


Due to updates in high level disinfection, Med Center Health has adopted a new product to clean and reprocess our scopes/ instruments. Metricide OPA is now utilized in all areas that reprocess scopes or any instrument requiring high level disinfection. The hospital also embraced a new method of transportation for all instruments. This allows for any instrument to be identified as clean or dirty by the carrier cover used. All updates went into effect July 2017.


Rishi Agarwal, M.D., board-certified oncologist with Medical Center Hematology & Oncology, began to see patients at The Medical Center at Caverna Specialty Clinic in April 2017. This new clinic allows for cancer patients to be seen close to home in Hart County and surrounding communities.

Quality Improvement

Braden Protocol on 4C (Oncology): The Medical Center at Bowling Green implemented a Braden protocol hospital-wide that would allow nurses to initiate an order set without physician approval if certain Braden scores were met. This order set allows many preventative items, consults, etc., to be ordered based on the Braden score. This has become an initiative at many institutions around the country and has proven to be an effective measure in preventing pressure ulcer incidence.


Physician Reviewer:
Richard McGahan, M.D.
Radiation Oncologist

Physician Study: CoC Standard 4.6 - 2018 Monitoring Compliance with National Evidence Based Guidelines for Prostate Cancer


The American Cancer Society’s estimates for prostate cancer in the United States for 2018 are 164,690 new cases and 29,430 deaths. One out of nine men will be diagnosed with prostate cancer during his lifetime. Prostate cancer develops mainly in older men and in African-American men—approximately six out of ten cases are diagnosed in men aged 65 or older. It is rare to be diagnosed before the age of 40 with the average age of diagnosis being 66. Prostate cancer is the second leading cause of cancer death in American men behind lung cancer. About one man in forty-one will die of prostate cancer. Although prostate cancer can be a serious disease, most men diagnosed do not die from it. More than 2.9 million men in the US who have been diagnosed with prostate cancer at some point are still alive today.

[Read Full Article]


The Medical Center
Cancer Treatment Center for Southern Kentucky
250 Park Street
Bowling Green, KY 42101

(270) 781-7178 or 1-800-745-1213
Cancer Registry (270) 745-1288

Barren River Regional Cancer Center
103 Trista Lane
Glasgow, KY 42141

(270) 651-2478 or 1-877-573-0050